Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Grant/Award of 753,600 ATNM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 753,600 | n/a |
| Aug 20, 2025 | Actinium Pharmaceuticals, Inc. (ATNM) | Tax Withholding | 120,900 | $206.7K |
| Apr 2, 2025 | Actinium Pharmaceuticals, Inc. (ATNM) | Disposition to Issuer | 16,666 | n/a |
| Dec 29, 2023 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 984,367 | n/a |
| Aug 19, 2022 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 300,000 | n/a |
| Jul 1, 2022 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 827,366 | n/a |
| Sep 3, 2021 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 310,182 | n/a |
| Aug 14, 2020 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 139,062 | n/a |